MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Newly identified cases of parkinsonism and prodromal PD in a remote LRRK2 G2019S cohort

J. Soto, S. Jensen-Roberts, T. Myers, M. Pawlik, E. Hartman, S. Lettenberger, A. Kaplan, R. Toor, R. Wilson, P. Auinger, E. Dorsey, B. Valdovinos, K. Amodeo, S. Sharma, R. Holloway, C. Tanner, R. Alcalay, R. Schneider (Rochester, USA)

Meeting: 2022 International Congress

Abstract Number: 1318

Keywords: Parkinson’s, Parkinsonism

Category: Parkinson's Disease: Genetics

Objective: To evaluate new cases of prodromal PD and concern for parkinsonism in a cohort of LRRK2 G2019S carriers.

Background: LRRK2 G2019S is a common cause of genetic PD that exhibits reduced penetrance. A better understanding of the transition from non-manifest to prodromal to manifest disease is needed. The Movement Disorder Society (MDS) prodromal PD criteria may be one strategy for identifying those at greatest risk of developing PD.

Method: Among LRRK2 G2019S carriers ≥ 50 years of age without PD enrolled in a prospective, longitudinal, remote study, we used the MDS prodromal PD criteria to calculate an overall likelihood ratio at each annual visit. Those with a likelihood ratio that exceeded the age-based minimum likelihood ratio necessary to meet the recommend 80% threshold were classified as prodromal PD.  During video-based visits, movement disorder experts blinded to self-reported PD status conducted a modified MDS – Unified Parkinson Disease Rating Scale (UPDRS) motor examination and identified cases of concern for parkinsonism.

Results: At baseline, 8% (10/127) of non-manifest participants ≥ 50 years of age met criteria for prodromal PD and 9% (20/217) of all non-manifest participants demonstrated parkinsonism.  At year one, 9% (11/126) met criteria for prodromal PD and 7% (14/204) demonstrated parkinsonism.  As of March 2022, at year two, 7% (7/94) met criteria for prodromal PD and 11% (15/136) demonstrated parkinsonism. One participant had prodromal PD and 3 had a concern for parkinsonism at baseline, year one, and year two consistently. Between baseline and year one, 7 new cases of parkinsonism and 3 new cases of prodromal PD were identified, with 2 participants meeting both criteria. Between year one and year two, 4 new cases of parkinsonism and 3 new cases of prodromal PD have been identified to date, with 2 participants meeting both criteria. Table 1 summarizes the change in motor, mood, and symptom scores for these 13 emergent cases. Of participants with prodromal PD and/or concern for parkinsonism there have been no new cases of self-reported PD.
[Table 1]
[Table 2]

Conclusion: While there have been a similar number of cases of parkinsonism and/or prodromal PD from year to year, designations have been unstable. Moreover, 13 new cases were identified over a short period of follow-up. The instability in designation may reflect limitations of the remote motor examination or fluctuations of symptoms.

MDS 2022 figure 1

MDS 2022 table 1

To cite this abstract in AMA style:

J. Soto, S. Jensen-Roberts, T. Myers, M. Pawlik, E. Hartman, S. Lettenberger, A. Kaplan, R. Toor, R. Wilson, P. Auinger, E. Dorsey, B. Valdovinos, K. Amodeo, S. Sharma, R. Holloway, C. Tanner, R. Alcalay, R. Schneider. Newly identified cases of parkinsonism and prodromal PD in a remote LRRK2 G2019S cohort [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/newly-identified-cases-of-parkinsonism-and-prodromal-pd-in-a-remote-lrrk2-g2019s-cohort/. Accessed June 19, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/newly-identified-cases-of-parkinsonism-and-prodromal-pd-in-a-remote-lrrk2-g2019s-cohort/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #23660 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley